Promising new drug trial for Juvenile Myelomonocytic Leukaemia Treatment
Washington: A recent study published in Cancer Discovery, a respected medical journal from the American Association for Cancer Research (AACR), highlights promising findings from a phase 2 clinical trial involving the drug Trametinib. This trial focused on its effectiveness in treating relapsed or refractory (R/R) juvenile myelomonocytic leukaemia (JMML). The study reported that 7 out […]
